Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation.
about
Mechanisms of HIV protein degradation into epitopes: implications for vaccine designIRAP identifies an endosomal compartment required for MHC class I cross-presentationBalancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation.PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing.The carboxypeptidase ACE shapes the MHC class I peptide repertoireThe role of insulin-regulated aminopeptidase in MHC class I antigen presentation.In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib moleculesComparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypesIdentification of T-cell epitopes for cancer immunotherapy.Post-proteasomal and proteasome-independent generation of MHC class I ligands.Production of an antigenic peptide by insulin-degrading enzyme.The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides.Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation.Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins.Large-Scale Identification of Common Trait and Disease Variants Affecting Gene Expression.BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.Concerted antigen processing of a short viral antigen by human caspase-5 and -10.
P2860
Q26866505-349200A9-3276-47C0-8339-012C380E0E59Q28114994-F7093864-8BA8-4BE3-AF05-FA0542623FADQ33728652-29161CAC-FA28-4DB4-A0D0-EF38511E9553Q34882801-32F5C425-E677-4026-90CD-60224E411629Q35402189-B725AEB9-FC48-4FD8-A649-A2AB0A5FA157Q35928365-9C77F64A-833E-4498-A1BF-E7F90D10E1E3Q36228447-24863C36-EFBD-4719-B124-26874523C416Q36853385-940873DF-50A9-4938-90DC-4454D17E4472Q36870592-0896295E-2979-4401-AA1A-8E9220525971Q37851391-93E5119D-2C4D-44D9-BCA3-290DAAD5E3E6Q39719024-B217090E-6D82-4F28-A9F6-9E286D2D9E58Q39814591-D1F3A0DD-89E8-4DF0-8B39-3D4D4631D379Q40066828-441DA3D6-62BF-4F29-967B-1750249D7849Q40169540-4666D6D9-B3ED-45F9-B46F-86A90E91A27DQ40196315-EE31CE2F-D291-497C-9113-EFD748285FBDQ40239641-77C1EBF3-56D9-4662-9327-4B202F74F12EQ41880609-A34CB9BB-A2BB-48E0-ACD0-9639B28ECB1D
P2860
Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Complexity, contradictions, an ...... class I antigen presentation.
@ast
Complexity, contradictions, an ...... class I antigen presentation.
@en
type
label
Complexity, contradictions, an ...... class I antigen presentation.
@ast
Complexity, contradictions, an ...... class I antigen presentation.
@en
prefLabel
Complexity, contradictions, an ...... class I antigen presentation.
@ast
Complexity, contradictions, an ...... class I antigen presentation.
@en
P2860
P1476
Complexity, contradictions, an ...... A class I antigen presentation
@en
P2093
Oliver Carroll
Yousra Hassainya
P2860
P356
10.1111/J.0105-2896.2005.00313.X
P577
2005-10-01T00:00:00Z